For example, the overexpression of P-glycoprotein (P-gp), a drug-efflux transporter, has been reported to be linked with the efflux of anti-cancer drugs, and also the clinical refractoriness of anti-cancer drugs is associated with P-gp [4]. This evidence concerns the gene PGP and cancer.